デフォルト表紙
市場調査レポート
商品コード
1356798

子宮内膜症市場レポート:2030年までの動向、予測、競合分析

Endometriosis Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円

ご注意: DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

子宮内膜症市場レポート:2030年までの動向、予測、競合分析
出版日: 2023年09月01日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

子宮内膜症の動向と予測

世界の子宮内膜症市場は、2024年から2030年までのCAGRが13.1%で、2030年までに推定31億米ドルに達すると予想されています。この市場の主な促進要因は、子宮内膜症研究のための資金が増加していること、感染症の発生やパンデミックの急増が観察されていること、子宮内膜症に対する意識が高まっていることです。世界の子宮内膜症市場の将来は、病院、在宅医療、専門センター市場における機会によって有望視されています。

子宮内膜症市場の洞察

Lucintelは、表在性腹膜病変の有病率の上昇に加え、子宮内膜症に対する認識を高めることを目的としたプログラムや子宮内膜症研究のための政府資金の増加により、予測期間中に表在性腹膜病変が最も高い成長を示すと予測しています。

病院は、病院薬局の数の増加と、質の高いサービスと設備による病院に対する患者の嗜好の高まりにより、最大のセグメントであり続けると思われます。

アジア太平洋は、子宮内膜症患者の有病率の増加と、同地域の市場参入企業による戦略的取り組みの増加により、予測期間中に最も高い成長が見込まれています。

本レポートでは、以下の11の主要な質問に回答している:

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か?
  • Q.2.今後成長が加速するセグメントとその理由は?
  • Q.3.今後成長が加速すると思われる地域とその理由は?
  • Q.4.市場力学に影響を与える主な要因は何か?市場における主な課題とビジネスリスクは?
  • Q.5.この市場におけるビジネスリスクと競合の脅威は?
  • Q.6.この市場における新たな動向とその理由は?
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか?
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は?
  • Q.9.この市場における主要企業は?主要企業は事業成長のためにどのような戦略的取り組みを進めているのか?
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか?
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか?

目次

第1章 エグゼクティブサマリー

第2章 世界の子宮内膜症市場:市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向(2018~2023年)と予測(2024~2030年)
  • 世界の子宮内膜症市場動向(2018-2023)と予測(2024-2030)
  • タイプ別の世界の子宮内膜症市場
    • 表在性腹膜病変
    • 子宮内膜腫
    • その他
  • 流通チャネル別の世界の子宮内膜症市場
    • 病院薬局
    • オンライン薬局
    • 小売薬局
  • 治療別の世界の子宮内膜症市場
    • 経口避妊薬
    • 性腺刺激ホルモン放出ホルモン(GnRH)薬
    • その他
  • 最終用途産業別の世界の子宮内膜症市場
    • 病院
    • ホームケア
    • 専門センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の子宮内膜症市場
  • 北米の子宮内膜症市場
  • 欧州の子宮内膜症市場
  • アジア太平洋子宮内膜症市場
  • その他地域子宮内膜症市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • タイプ別の世界の子宮内膜症市場の成長機会
    • 流通チャネル別の世界の子宮内膜症市場の成長機会
    • 治療法別の世界の子宮内膜症市場の成長機会
    • 最終用途産業別の世界の子宮内膜症市場の成長機会
    • 地域別の世界の子宮内膜症市場の成長機会
  • 世界の子宮内膜症市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の子宮内膜症市場の能力拡大
    • 世界の子宮内膜症市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Consilient Health
  • Sun Pharmaceutical
  • Sanofi
  • AstraZeneca
  • Serum Institute of India
  • Pfizer
  • Teva Pharmaceutical Industries
  • GlaxoSmithKline
  • Merck
  • Abbott Laboratories
目次

Endometriosis Trends and Forecast

The future of the global endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets. The global endometriosis market is expected to reach an estimated $3.1 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

A more than 150-page report is developed to help in your business decisions.

Endometriosis by Segment

The study includes a forecast for the global endometriosis by type, distribution channel, treatment, end use industry, and region.

Endometriosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Superficial Peritoneal Lesion
  • Endometriomas
  • Others

Endometriosis Market by Distribution channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Endometriosis Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Oral Contraceptives
  • Gonadotropin-Releasing Hormone (GnRH) Medicines
  • Others

Endometriosis Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Homecare
  • Speciality Centers
  • Others

Endometriosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Endometriosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endometriosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endometriosis companies profiled in this report include-

  • Consilient Health
  • Sun Pharmaceutical
  • Sanofi
  • Astrazeneca
  • Serum Institute Of India
  • Pfizer
  • Teva Pharmaceutical Industries
  • Glaxosmithkline
  • Merck
  • Abbott Laboratories

Endometriosis Market Insights

Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Hospitals will remain the largest segment due to the increase in the number of hospital pharmacies and growing patient preference for hospitals due to their high-quality services and facilites.

APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Features of the Global Endometriosis Market

Market Size Estimates: Endometriosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Endometriosis market by various segments, such as by type, distribution channel, treatment, end use industry and region in terms of($B).

Regional Analysis: Endometriosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, treatments, end use industries, and region.s for the endometriosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endometriosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the endometriosis market size?

Answer: The global endometriosis market is expected to reach an estimated $3.1 billion by 2030.

Q.2. What is the growth forecast for endometriosis market?

Answer: The global endometriosis market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the endometriosis market?

Answer: The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

Q.4. What are the major segments for endometriosis market?

Answer: The future of the endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets.

Q.5. Who are the key Endometriosis Market companies?

Answer: Some of the key endometriosis companies are as follows:

  • Consilient Health
  • Sun Pharmaceutical
  • Sanofi
  • AstraZeneca
  • Serum Institute of India
  • Pfizer
  • Teva Pharmaceutical Industries
  • GlaxoSmithKline
  • Merck
  • Abbott Laboratories

Q.6. Which endometriosis market segment will be the largest in future?

Answer: Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Q.7. In endometriosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the endometriosis market by type (superficial peritoneal lesion, endometriomas, and others), distribution channel (hospital pharmacy, online pharmacy, and retail pharmacy), treatment (oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines, and others), end use industry (hospitals, homecare, speciality centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Endometriosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Endometriosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Endometriosis Market by Type
    • 3.3.1: Superficial Peritoneal Lesion
    • 3.3.2: Endometriomas
    • 3.3.3: Others
  • 3.4: Global Endometriosis Market by Distribution channel
    • 3.4.1: Hospital Pharmacy
    • 3.4.2: Online Pharmacy
    • 3.4.3: Retail Pharmacy
  • 3.5: Global Endometriosis Market by Treatment
    • 3.5.1: Oral Contraceptives
    • 3.5.2: Gonadotropin-Releasing Hormone (GnRH) Medicines
    • 3.5.3: Others
  • 3.6: Global Endometriosis Market by End Use Industry
    • 3.6.1: Hospitals
    • 3.6.2: Homecare
    • 3.6.3: Speciality Centers
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Endometriosis Market by Region
  • 4.2: North American Endometriosis Market
    • 4.2.2: North American Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
  • 4.3: European Endometriosis Market
    • 4.3.1: European Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
    • 4.3.2: European Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
  • 4.4: APAC Endometriosis Market
    • 4.4.1: APAC Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
    • 4.4.2: APAC Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
  • 4.5: ROW Endometriosis Market
    • 4.5.1: ROW Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
    • 4.5.2: ROW Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Endometriosis Market by Type
    • 6.1.2: Growth Opportunities for the Global Endometriosis Market by Distribution channel
    • 6.1.3: Growth Opportunities for the Global Endometriosis Market by Treatment
    • 6.1.4: Growth Opportunities for the Global Endometriosis Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global Endometriosis Market by Region
  • 6.2: Emerging Trends in the Global Endometriosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Endometriosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Endometriosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Consilient Health
  • 7.2: Sun Pharmaceutical
  • 7.3: Sanofi
  • 7.4: AstraZeneca
  • 7.5: Serum Institute of India
  • 7.6: Pfizer
  • 7.7: Teva Pharmaceutical Industries
  • 7.8: GlaxoSmithKline
  • 7.9: Merck
  • 7.10: Abbott Laboratories